JPS57123166A - Pyrazoline derivative - Google Patents

Pyrazoline derivative

Info

Publication number
JPS57123166A
JPS57123166A JP56202376A JP20237681A JPS57123166A JP S57123166 A JPS57123166 A JP S57123166A JP 56202376 A JP56202376 A JP 56202376A JP 20237681 A JP20237681 A JP 20237681A JP S57123166 A JPS57123166 A JP S57123166A
Authority
JP
Japan
Prior art keywords
pyrazoline derivative
pyrazoline
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56202376A
Other languages
English (en)
Inventor
Chiyaaruzu Kotsu Furederitsuku
Goodon Karudoueru Arubaato
Koraado Debitsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of JPS57123166A publication Critical patent/JPS57123166A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77—Hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56202376A 1980-12-16 1981-12-15 Pyrazoline derivative Pending JPS57123166A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8040172 1980-12-16

Publications (1)

Publication Number Publication Date
JPS57123166A true JPS57123166A (en) 1982-07-31

Family

ID=10518005

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56202376A Pending JPS57123166A (en) 1980-12-16 1981-12-15 Pyrazoline derivative

Country Status (4)

Country Link
US (1) US4564684A (ja)
JP (1) JPS57123166A (ja)
BE (1) BE891489A (ja)
ZA (1) ZA818703B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824859A (en) * 1983-05-21 1989-04-25 Fisons Plc. Pyrazoline compounds compositions and use
EP0178035B1 (en) * 1984-05-12 1990-01-03 FISONS plc Anti-inflammatory 1,n-diarylpyrazol-3-amines, compositions containing them and processes for their preparation
US4677210A (en) * 1985-06-19 1987-06-30 Rorer Pharmaceutical Corporation 1-arylalkoxy- and 1-arylalkylthioaryl-2-pyrazolines as anti-inflammatory or anti-allergic agents
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
FR2781147B1 (fr) 1998-07-20 2000-09-15 Oreal Compositions pour la teinture des fibres keratiniques contenant des derives de 3-amino pyrazolines a titre de coupleur, procede de teinture et kit de teinture

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2726248A (en) * 1950-04-06 1955-12-06 Ilfrod Ltd 3-amino pyrazolines and process
IT1061812B (it) * 1976-06-25 1983-04-30 Montedison Spa Processo per la preparazione di i fenil 3 ammino pirazoli
SU682865A1 (ru) * 1977-02-04 1979-08-30 Ленинградский Филиал Всесоюзного Научно-Исследовательского Института Химико-Фотографической Промышленности Про вл ющий раствор дл обработки галогенсеребр ных черно-белых фотографических материалов

Also Published As

Publication number Publication date
US4564684A (en) 1986-01-14
BE891489A (fr) 1982-06-15
ZA818703B (en) 1983-07-27

Similar Documents

Publication Publication Date Title
ZA816809B (en) Aminoalkylfuran derivative
JPS5711987A (en) Novel imidazo-rifamycin derivative
JPS5785379A (en) 3-aryl-5-isothiazole derivative
JPS56128755A (en) Proline derivative
JPS56150050A (en) Oxitocin derivative
JPS5781476A (en) Isooxazolylbenzamide derivative
ZA839640B (en) Pyrazoline insecticides
EP0058424A3 (en) Pyrazoline derivatives
GB2122188B (en) Pyrazole derivative
JPS5758674A (en) Benzodiazepine derivative
JPS56113786A (en) Benzodiazepine derivative
GB2088365B (en) Moranoline derivative
PH18633A (en) Novel antrancyclinone derivative
GB2067989B (en) Bis-moranoline derivatives
JPS5742688A (en) Substituted n-alkylimidazole derivative
JPS56125375A (en) Benzodiazepin derivative
JPS577467A (en) Novel phenylpropargylamine derivative
GB2089792B (en) Substituted benzopyranotriazoles
ZW9881A1 (en) Substituted phenoxyaminopropanol derivatives
JPS5793949A (en) Alpha-cyanophenoxybenzylamine derivative
JPS56118057A (en) Carboxamidine derivative
ZA823934B (en) Novel bis-triazole derivative
JPS56150069A (en) Imidazole hydrazone derivative
JPS57118540A (en) Bis-aminomethyl-anthraquinone derivative
JPS57131768A (en) Novel 2-pyrazoline derivative